败血症中的免疫抑制:生物标志物和专门的亲解决媒介
Cristina M Padovani1, Kingsley Yin1
1Department of Cell Biology and Neuroscience, Rowan-Virtua School of Translational Biomedical Engineering and Sciences, Virtua Health College of Life Sciences of Rowan University, Stratford, NJ 08084, USA.
Biomedicines
|January 23, 2024
概括
败血症涉及有害的炎症和后来的免疫抑制,使治疗变得困难. 本综述涵盖了败血症诱导的免疫抑制机制,生物标志物和潜在的治疗方法,如专门的亲解决媒介 (SPMs).
科学领域:
- 免疫学 免疫学 免疫学
- 关键护理医学 关键护理医学
- 病理生理学 病理生理学
背景情况:
- 败血症会引发复杂的免疫反应,最初是超炎症性的,导致器官损伤.
- 败血症的晚期包括矛盾的免疫抑制,增加对二次感染的易感性.
- 目前的败血症治疗挑战包括区分免疫阶段和缺乏治疗方法来解决炎症而不会导致免疫抑制.
研究的目的:
- 审查驱动败血症诱导免疫抑制的主要机制.
- 为了确定关键的生物标志物,表明了败血症的免疫抑制阶段.
- 探索专门的亲解决调解剂 (SPMs) 作为抗炎和非免疫抑制剂的潜力.
主要方法:
- 在PubMed数据库的文献综述.
- 使用的关键词:败血症,淋巴细胞亡,巨细胞枯竭,髓质衍生抑制细胞 (MDSC),生物标志物和SPM.
- 专注于三个主要的免疫抑制机制:淋巴细胞亡,单细胞/巨细胞枯竭和MDSC迁移.
主要成果:
- 关键的免疫抑制机制包括淋巴细胞亡,巨细胞枯竭和增加的MDSC迁移.
- 败血性免疫抑制的生物标志物包括MDSCs和IL-10的升高,淋巴细胞和HLA-DR的减少,以及GPR18.
- 在临床前模型中,专门的亲解决媒介 (SPMs) 在没有免疫抑制的情况下解决炎症的承诺.
结论:
- 了解败血症诱导的免疫抑制机制和生物标志物对于有效治疗至关重要.
- 骨髓衍生抑制细胞 (MDSC) 和相关生物标志物在败血性免疫抑制中发挥着重要作用.
- 专门的亲解决媒介 (SPMs) 代表了败血症的潜在治疗途径,在没有免疫抑制的情况下提供抗炎作用.
相关概念视频
01:28Inflammatory Response
2.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K
01:17Drugs Used in Lower Respiratory Disorders: Overview
445
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
445